DAO Council & Regenesis Labs – Quarterly RFI – Q2 2026

DAO Council & Regenesis Labs – Quarterly RFI – Q2 2026

We are excited to launch the first round of RFI submissions under the newly established procedure.

This RFI round will remain open for a continuous period of 30 days for community members to submit their questions through the provided FORM. Once the current round of submissions is complete, a new round will be opened for further inquiries.

Please visit the specifications thread for a better understanding of the procedure and the form.

REMINDER: Please note that only posts relevant to the submission of RFIs will be allowed in the designated threads, and any unrelated posts will be subject to removal.

1 Like

DAO Council & Regenesis Labs – Quarterly RFI – Q2 2026 - Responses

During the period this RFI form was open, we received one questionnaire, which is answered below. This response should have been published much earlier, but due to the reasons mentioned above, we were unable to do so.

We are committed to preventing situations like this in the future and to providing timely responses going forward.

Questionnaire:

  1. Is the full attestation report — including any management letters, findings, or supporting documentation — available to the community, or is the summary version included in the Q4 2025 Transparency Report the complete public record?

  2. The Q4 2025 Independent Attestation Report states that “minor reconciling differences” were found and resolved with “no material impact to the Q4 financials.” What were those differences specifically — what accounts, transactions, or categories were involved?

  3. What caused those reconciling differences and how were they resolved?

Response:

1. The Independent Attestation Report included in Annex B of the Q4 2025 Transparency Report is the complete report made available for public purposes. A more detailed internal version exists for Council oversight, consistent with standard audit practice. That internal version includes information subject to confidentiality obligations that DCL Regenesis Labs, as the contracting party, owes to its consultants, contractors, and vendors under their respective agreements (compensation terms, individual invoices, and similar data). Maryana, as Independent Examiner, is separately committed by a confidentiality agreement restricting disclosure of that material without prior written consent. The published Transparency Report reflects the level of detail RGL can share publicly while honoring those obligations.

2 & 3. The reconciling differences were categorization/tracking items between the Request Finance expense listing and the internal Cash Flow reporting file — specifically (a) some travel expense reimbursements not yet reflected in the Personnel Cost tab, (b) some equipment purchases not yet reflected in that same tab and (c) one duplicate line item in the Cash Flow file — two entries recorded for the same payment when only one was payable. These are from manual updates to the Cash Flow file not yet being fully synced with Request Finance exports at the time of review. The team provided supporting documentation for each item, corrected the file, and the examiner confirmed no impact on reported balances or the Q4 financials.

For more details on how the report is generated and how the audits are conducted: